Evidence mapPaperPMID 25383674Full record

ArticleInternational journal of molecular sciences2014

Nrf2 and redox status in prediabetic and diabetic patients.

Angélica S Jiménez-Osorio, Alejandra Picazo, Susana González-Reyes, Diana Barrera-Oviedo, Martha E Rodríguez-Arellano, José Pedraza-Chaverri

Open access · goldAbstract read
In one paragraph

Article in International journal of molecular sciences, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 47 papers.

0numbers the graph read from it
0cells of the map it votes in
47citing papers in PubMed
3.3field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

47 citing papers in PubMed, 95 citations in OpenAlex.

  1. Trial
  2. Trial
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Review
  11. Sestrin2 in diabetes and diabetic complications.Frontiers in endocrinology · 2023
    Review
  12. Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Angélica S Jiménez-OsorioFaculty of Chemistry, Department of Biology, National Autonomous University of Mexico (UNAM), University City 04510 DF, Mexico. joas17@hotmail.com.
Alejandra PicazoFaculty of Medicine, Department of Pharmacology, National Autonomous University of Mexico (UNAM), University City 04510 DF, Mexico. alepicazo1980@gmail.com.
Susana González-ReyesFaculty of Chemistry, Department of Biology, National Autonomous University of Mexico (UNAM), University City 04510 DF, Mexico. suxan05@gmail.com.
Diana Barrera-OviedoFaculty of Medicine, Department of Pharmacology, National Autonomous University of Mexico (UNAM), University City 04510 DF, Mexico. dianabarrera@hotmail.com.
Martha E Rodríguez-ArellanoResearch Department, Hospital Regional "Lic. Adolfo López Mateos", ISSSTE, Av. Universidad 1321, Florida 01030 DF, Mexico. marthaeunicer@yahoo.com.mx.
José Pedraza-ChaverriFaculty of Chemistry, Department of Biology, National Autonomous University of Mexico (UNAM), University City 04510 DF, Mexico. pedraza@unam.mx.
Universidad Nacional Autónoma de México · MXInstitute for Social Security and Services for State Workers · MX

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The redox status associated with nuclear factor erythroid 2-related factor-2 (Nrf2) was evaluated in prediabetic and diabetic subjects. Total antioxidant status (TAS) in plasma and erythrocytes, glutathione (GSH) and malondialdehyde (MDA) content and activity of antioxidant enzymes were measured as redox status markers in 259 controls, 111 prediabetics and 186 diabetic type 2 subjects. Nrf2 was measured in nuclear extract fractions from peripheral blood mononuclear cells (PBMC). Nrf2 levels were lower in prediabetic and diabetic patients. TAS, GSH and activity of glutamate cysteine ligase were lower in diabetic subjects. An increase of MDA and superoxide dismutase activity was found in diabetic subjects. These results suggest that low levels of Nrf2 are involved in the development of oxidative stress and redox status disbalance in diabetic patients.

Indexed as

AdultAge FactorsAntioxidant Response ElementsAntioxidantsBiomarkersCase-Control StudiesDiabetes Mellitus, Type 2FemaleGlycated HemoglobinHospitalizationHumansMaleMiddle AgedNF-E2-Related Factor 2Oxidation-ReductionPrediabetic StateAntioxidantsBiomarkersGlycated HemoglobinNF-E2-Related Factor 2

Identifiers

PMID25383674
PMCPMC4264167
OpenAlexW2026516234

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.